ACM
EXAS

Altium Capital Management’s Exact Sciences EXAS Stock Holding History

Altium Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,000
Closed -$5.62M – 44
2024
Q4 		$5.62M Buy
+100,000
New +$6.22M 1.59% 23
2022
Q1 		– Sell
-44,000
Closed -$3.42M – 131
2021
Q4 		$3.42M Buy
+44,000
New +$3.88M 0.94% 41

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altium Capital Management's EXAS Position: Q1 2025 in Review

Altium Capital Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 100,000 shares — an estimated $5.62M sold.

Altium Capital Management first reported a position in EXAS in Q4 2021 and held it in 2 quarters. The position peaked at $5.62M in Q4 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Altium Capital Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 100,000 Exact Sciences shares in Q1 2025, an estimated $5.62M.
  • Altium Capital Management first reported a position in Exact Sciences in Q4 2021 and held it in 2 quarters.
  • Altium Capital Management's Exact Sciences position peaked at $5.62M in Q4 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.